{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-004733","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2026-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.559049+00:00","generated_at":"2026-05-16T05:36:44.762950+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Regen Biopharma issues 21.4M shares in Jan 2026 for $69,550, massive dilution","bullets":["On Jan 15, 2026, issued 5,000,000 shares to satisfy $11,449 principal + $8,101 interest on convertible debt.","On Jan 29, 2026, issued 5,302,732 shares to satisfy $12,000 principal + $1,000 interest.","On Jan 30, 2026, issued 11,111,111 shares for $50,000 cash via Reg A offering.","As of Feb 2, 2026, total shares outstanding: 129,468,577; implied average issuance price ~$0.003 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-004733","json":"https://secwatch.observer/filing/0001493152-26-004733.json","markdown":"https://secwatch.observer/filing/0001493152-26-004733.md","text":"https://secwatch.observer/filing/0001493152-26-004733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226004733/0001493152-26-004733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226004733/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:36:44.762950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}